Showing results (761-770 of 3,852) with videos related to
Sort By:
Pageof 386
Cancer Cell|February 7, 2017
Comprehensive Molecular Characterization of Pheochromocytoma and ParagangliomaLauren Fishbein, Ignaty Leshchiner, Vonn Walter, et al.Cancer Cell|March 20, 2019
No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AMLRozario Thomas, Ravindra MajetiCancer Cell|March 20, 2019
Serine and Methionine Metabolism: Vulnerabilities in Lethal Prostate CancerXia Gao, Jason W Locasale, Michael A ReidCancer Cell|March 20, 2019
Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic ResistanceJonathan Cooper, Filippo G GiancottiCancer Cell|March 20, 2019
The Proteogenomic Landscape of Curable Prostate CancerAnkit Sinha, Vincent Huang, Julie Livingstone, et al.Cancer Cell|March 20, 2019
Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor TargetingShivani Srivastava, Alexander I Salter, Denny Liggitt, et al.Cancer Cell|November 20, 2018
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain MutationsKanika Bajaj Pahuja, Thong T Nguyen, Bijay S Jaiswal, et al.Cancer Cell|April 12, 2017
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSebastian Mohr, Carmen Doebele, Federico Comoglio, et al.Cancer Cell|April 12, 2017
Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer ProgressionAshleigh R Poh, Christopher G Love, Frederick Masson, et al.Cancer Cell|April 12, 2017
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory CancersPer Hydbring, Yinan Wang, Anne Fassl, et al.Pageof 386